Edgewise Therapeutics EWTX
Last Price
52 Week Range
$10.60 - $30.48
Next Earnings Date
Mar 02 2026 (Estimate)
Next Earnings Date
Mar 02 2026 (Est.)
Last Price
EWTX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Edgewise Therapeutics, Inc. | 8-K | November 20, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | November 10, 2025 | |
Edgewise Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | November 6, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | August 7, 2025 | |
Edgewise Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | June 26, 2025 | |
Edgewise Therapeutics, Inc. | DEFA14A | May 14, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | May 8, 2025 | |
Edgewise Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Edgewise Therapeutics, Inc. | DEFA14A | April 29, 2025 | |
Edgewise Therapeutics, Inc. | DEF 14A | April 29, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | April 2, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | April 2, 2025 | |
Edgewise Therapeutics, Inc. | 10-K | March 3, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | March 3, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | January 22, 2025 | |
Edgewise Therapeutics, Inc. | 8-K | December 16, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | November 7, 2024 | |
Edgewise Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | August 12, 2024 | |
Edgewise Therapeutics, Inc. | 10-Q | August 8, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | August 8, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | June 11, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | May 10, 2024 | |
Edgewise Therapeutics, Inc. | S3ASR | May 10, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | May 9, 2024 | |
Edgewise Therapeutics, Inc. | 10-Q | May 9, 2024 | |
Edgewise Therapeutics, Inc. | 8-K | May 7, 2024 | |
Edgewise Therapeutics, Inc. | DEFA14A | May 7, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.